RenBio’s $24 Million Series A Financing and Covid-19 Antibody Agreement

Martina Bellini
Tagged:

Morgan Lewis represented RenBio Inc. in the transaction.RenBio Inc. closed a $24 million Series A investment and a license agreement with Columbia University for exclusive worldwide development…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here